Get access to our best features
Get access to our best features
Published

Federal judge allows red states to resume lawsuit against mifepristone

  • A judge in Texas ruled that Idaho, Kansas, and Missouri can continue their lawsuit against federal rules on mifepristone access.
  • The states want the FDA to ban telehealth prescriptions for mifepristone and limit its use to the first seven weeks of pregnancy.
  • Mifepristone is commonly used for medication abortions, which have increased since the Supreme Court's 2022 ruling on abortion rights.
  • The states are challenging recent FDA updates that have made access to mifepristone easier rather than seeking to revoke its approval entirely.
Insights by Ground AI
Does this summary seem wrong?
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 64% of the sources are Center
63% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)